hardcover. Condition: Sehr gut. 660 Seiten; 9781461411437.2 Gewicht in Gramm: 2.
Hardcover. Condition: As New. 2. Auflage. Unread, like new. Immediately dispatched from Germany.
Hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Language: English
Published by Lap Lambert Academic Publishing, 2012
ISBN 10: 3659166219 ISBN 13: 9783659166211
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 156 pages. 8.66x5.91x0.32 inches. In Stock.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 148.08
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: New. pp. XIV, 779 210 illus., 84 illus. in color. Softcover reprint of the original 2nd ed. 2016 edition NO-PA16APR2015-KAP.
Condition: new.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Formulating Poorly Water Soluble Drugs | Robert O. Williams Iii (u. a.) | Taschenbuch | xiv | Englisch | 2018 | Springer | EAN 9783319826189 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Condition: gut. 2011. Formulating Poorly Water Soluble Drugs (AAPS Advances in the Pharmaceutical Sciences Series, 3, Band 3) In deutscher Sprache. pages.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 189.04
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659166219 ISBN 13: 9783659166211
Seller: Mispah books, Redhill, SURRE, United Kingdom
paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Condition: new.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The objective of this volume isto consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.
Language: English
Published by Springer Nature Switzerland AG, Cham, 2022
ISBN 10: 3030887189 ISBN 13: 9783030887186
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condition: new. Hardcover. The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientists approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compounds physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop. The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Formulating Poorly Water Soluble Drugs | Robert O. Williams Iii (u. a.) | Taschenbuch | xii | Englisch | 2014 | Springer | EAN 9781489985927 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 209.52
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 209.52
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: English
Published by Springer, Berlin|Springer International Publishing|American Association of Pharmaceutical Scientists|Springer, 2023
ISBN 10: 3030887219 ISBN 13: 9783030887216
Seller: moluna, Greven, Germany
Kartoniert / Broschiert. Condition: New.
Language: English
Published by Springer, Berlin|Springer International Publishing|American Association of Pharmaceutical Scientists|Springer, 2021
ISBN 10: 3030887189 ISBN 13: 9783030887186
Seller: moluna, Greven, Germany
Gebunden. Condition: New.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 660.
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - A pharmaceutical scientist s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop. There are numerous literature resources available to pharmaceutical scientists to educate and provide guidance toward formulations development with poorly water-soluble drugs; however, a single, comprehensive reference is lacking. Furthermore, without access to a vast journal library, the detailed methods used to implement these approaches are not available. The objective of this volume is therefore to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume is intended to provide the reader with a breadth of understanding regarding the many challenges faced with the formulation of poorly water-soluble drugs as well as in-depth knowledge in the critical areas of development with these compounds. Further, this book is designed to provide practical guidance for overcoming formulation challenges toward the end goal of improving drug therapies with poorly water-soluble drugs. Enhancing solubility via formulation intervention is a unique opportunity in which formulation scientists can enable drug therapies by creating viable medicines from seemingly undeliverable molecules. With the ever increasing number of poorly water-soluble compounds entering development, the role of the formulation scientist is growing in importance. Also, knowledge of the advanced analytical, formulation, and process technologies as well as specific regulatory considerations related to the formulation of these compounds is increasing in value. Ideally, this book will serve as a useful tool in the education of current and future generations of scientists, and in this context contribute toward providing patients with new and better medicines.
Taschenbuch. Condition: Neu. Formulating Poorly Water Soluble Drugs | Robert O. Williams Iii (u. a.) | Taschenbuch | AAPS Advances in the Pharmaceutical Sciences Series | xii | Englisch | 2023 | Springer | EAN 9783030887216 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. Like New. book.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 660 pages. 9.25x6.10x1.42 inches. In Stock.
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The objective of thisthird editionis to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess ataminimum a working knowledge of each of theabove mentionedfacetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The objective of thisthird editionis to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess ataminimum a working knowledge of each of theabove mentionedfacetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.